DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Q2 Results, Nov 2: ITC, Marico, NALCO, UPL, NLC India, Tata Investment Corp, ESDS Software Solution, others to post earnings

Upstox 9 hrs ago·2 Nov 2026, 2:16 am

ESDS Software Solution is set to announce its financial results for the second quarter of the fiscal year. This earnings report will provide investors with a crucial update on the company's financial health, including its revenue performance and profitability for the recent period.

For investors, these results are important as they offer insight into ESDS' operational efficiency and growth trajectory. The company operates in the software services sector, so the outcome will help gauge its competitive position and ability to manage costs in a challenging market environment.

Investors should watch for the management commentary on future order inflows and the overall demand for the company's software solutions. Any guidance provided regarding the upcoming quarters will be a key factor in assessing the stock's potential performance.